Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy

ISTH Academy, Heyu Ni, 4147930

International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery

ISTH Academy, An Stroobants, 4151066

Impact of self-reported race on Villalta Scale postthrombotic syndrome scores and correlation with venous disease-specific quality of life: an exploratory analysis of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis Trial

ISTH Academy, Susan Kahn, 4151065

Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

ISTH Academy, Faculty / Presenters, 4151064

Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)

ISTH Academy, Faculty / Presenters, 4151063

Development and internal validation of a simple clinical score for the estimation of the probability of deep vein thrombosis in outpatient emergency department patients

ISTH Academy, Faculty / Presenters, 4151062

Complement-mediated hemolytic uremic syndrome associated with postpartum hemorrhage: case series and systematic review of individual participant data

ISTH Academy, Faculty / Presenters, 4151061

Stability of the thromboxane B biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples

ISTH Academy, Faculty / Presenters, 4151060

Maternal thrombocytopenia is not predictive of neonatal thrombocytopenia: a single-center Irish study

ISTH Academy, Faculty / Presenters, 4151059

Dependence of clot structure and fibrinolysis on apixaban and clotting activator

ISTH Academy, , 4151053

Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives

ISTH Academy, Floor Heubel-Moenen, 4151043

Annoucements

ISTH Academy, Faculty / Presenters, 4147937

Corrigendum to ‘COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry’ [Journal of Thrombosis and Haemostasis Volume 22, Issue 1, January 2024, Pages 61-75]

ISTH Academy, Faculty / Presenters, 4147936

The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia

ISTH Academy, Faculty / Presenters, 4147935

Endothelial protein disulfide isomerase A1 enhances membrane stiffness and platelet-endothelium interaction in hyperglycemia via SLC3A2 and LAMC1

ISTH Academy, Faculty / Presenters, 4147934

Small molecules targeting GRP78 mitigate anti-GRP78 autoantibody–mediated tissue factor procoagulant activity in cultured endothelial cells

ISTH Academy, , 4147933

Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes

ISTH Academy, Emad Tajkhorshid, 4147932

CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways

ISTH Academy, John Semple, 4147931

Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants

ISTH Academy, Faculty / Presenters, 4151067

Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets

ISTH Academy, Joseph Italiano, 4147929

Brain-derived gangliosides prime human platelet aggregation and induce platelet-leukocyte aggregate formation

ISTH Academy, Faculty / Presenters, 4147928

Fibrinolysis is impaired in patients with primary immune thrombocytopenia

ISTH Academy, Johanna Gebhart, 4147927

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms

ISTH Academy, Faculty / Presenters, 4147926

Issue Information

ISTH Academy, Faculty / Presenters, 4147903

Recognizing the 11th Year of World Thrombosis Day: A Call to Action for Health Care Professionals with a Focus on Women and Thrombosis

ISTH Academy, , 4147904

Adeno-associated viral vector integration: implications for long-term efficacy and safety

ISTH Academy, Faculty / Presenters, 4147905

Targeted treatments for vascular malformations: current state of the art

ISTH Academy, Miikka Vikkula, 4147906

Coagulation protease–induced extracellular vesicles: their potential effects on coagulation and inflammation

ISTH Academy, L Vijaya Mohan Rao, 4147907

Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review

ISTH Academy, Stephane Zuily, 4147908

The molecular background of quantitative defects of von Willebrand factor

ISTH Academy, Ferdows Atiq, 4147909

A new track for KDELivery of designer cargo by platelets

ISTH Academy, Freda Passam, 4147910

Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study

ISTH Academy, Faculty / Presenters, 4147911

Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors

ISTH Academy, Qizhen Shi, 4147912

Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study

ISTH Academy, Faculty / Presenters, 4147913

Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by 1-stage assays with prothrombin time vs Ecarin reagents

ISTH Academy, Catherine Hayward, 4147914

Rapid and ordered cleavage of prothrombin by Hopsarin D in the absence of phospholipid membranes

ISTH Academy, James Huntington, 4147915

Gene therapy for people with hemophilia B: a proposed care delivery model in Italy

ISTH Academy, Flora Peyvandi, 4147916

Production of physiological amounts of hemostatic proteins by human donor livers during ex situ long-term normothermic machine perfusion for up to 7 days

ISTH Academy, Ton Lisman, 4147917

Evaluating the safety and effectiveness of direct oral anticoagulants compared with warfarin in very elderly patients with atrial fibrillation with and without low bodyweight

ISTH Academy, Faculty / Presenters, 4147918

Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study

ISTH Academy, , 4147919

Development of A structured integrated post-Pulmonary Embolism care model: The Attend-PE model

ISTH Academy, Faculty / Presenters, 4147920

Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis

ISTH Academy, Faculty / Presenters, 4147921

Elevated lipopolysaccharide level is largely driven by time since symptom onset in acute ischemic stroke: the impact on clinical outcomes

ISTH Academy, Anetta Undas, 4147922

Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trial

ISTH Academy, , 4147923

Hereditary antithrombin deficiency pilot project registry from the American Thrombosis and Hemostasis Network

ISTH Academy, Faculty / Presenters, 4147924

Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity

ISTH Academy, James Luyendyk, 4147925

Monitoring and Reversal for Factor Xa Inhibitors

ISTH Academy, Faculty / Presenters, 4145875

Research Careers Outside Academia

ISTH Academy, Faculty / Presenters, 4144121

Anticoagulation for stroke prevention in AFib and treatment of VTE and PVT in cirrhosis

ISTH Academy, Faculty / Presenters, 4147521

Advancing Women's Health: Understanding Thrombosis

ISTH Academy, Faculty / Presenters, 4147561

Gene Therapy in Hemophilia: Clinical Care Strategies for Gene Therapy

ISTH Academy, Faculty / Presenters, 4144127

External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2

ISTH Academy, Faculty / Presenters, 4147422

Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis

ISTH Academy, Faculty / Presenters, 4147421

Conformation of factor Xa in solution revealed by single-molecule spectroscopy

ISTH Academy, Enrico Di Cera, 4147420

Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors

ISTH Academy, Faculty / Presenters, 4147419

R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI

ISTH Academy, James O'Donnell, 4147418

Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL

ISTH Academy, Faculty / Presenters, 4147417

Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate

ISTH Academy, Faculty / Presenters, 4147416

How to treat patients with bleeding disorder of unknown cause?

ISTH Academy, Floor Heubel-Moenen, 4150065

Balancing safety and efficacy of low-molecular-weight heparins in neonates: a systematic review

ISTH Academy, Irene Klaassen, 4150066

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study

ISTH Academy, Andreas Tiede, 4150067

Hyperfibrinolysis: a crucial phenotypic abnormality of posttraumatic fibrinolytic dysfunction

ISTH Academy, Faculty / Presenters, 4150068

Mathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII-, IX-, or XI-deficient blood

ISTH Academy, Faculty / Presenters, 4150069

Impact of the VTE-PREDICT calculator on clinicians’ decision making in fictional patients with venous thromboembolism: a randomized controlled trial

ISTH Academy, Mathilde Nijkeuter, 4150070

The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization

ISTH Academy, Merel Hellemons, 4150071

Incident thrombocytopenia and bleeding risk in elderly patients with atrial fibrillation on direct oral anticoagulants: insights from the ATHEROsclerosis in Atrial Fibrillation study

ISTH Academy, Daniele Pastori, 4150072

Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause

ISTH Academy, Faculty / Presenters, 4150073

Thrombin generation to evaluate the complex hemostatic balance of hemophilia A plasma containing direct oral anticoagulant and supplemented by factor VIII

ISTH Academy, Faculty / Presenters, 4150074

Clinical features and treatment of 70 children with lupus anticoagulant-hypoprothrombinemia syndrome: a retrospective study from a single center in China

ISTH Academy, , 4150075

Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores

ISTH Academy, Gabriela Cesarman Maus, 4150076

Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist

ISTH Academy, Rolf Urbanus, 4150077

Efficacy and safety of hetrombopag in the treatment of recombinant human thrombopoietin–resistant thrombocytopenia after allogeneic hematopoietic stem cell transplantation

ISTH Academy, , 4150078

Bleeding and quality of life in people with Glanzmann thrombasthenia—insights from the Glanzmann’s 360 study

ISTH Academy, Faculty / Presenters, 4150079

A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del)

ISTH Academy, Faculty / Presenters, 4147424

Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model

ISTH Academy, Samantha Gouw, 4150081

Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options

ISTH Academy, Faculty / Presenters, 4150082

Loss of endogenous Nox2-NADPH oxidase does not prevent age-induced platelet activation and arterial thrombosis in mice

ISTH Academy, Sanjana Dayal, 4150083

Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin–deficient patients: Data from the Rare Bleeding disorders in the Netherlands study

ISTH Academy, Saskia Schols, 4150084

Extracellular vesicle tissue factor and tissue factor pathway inhibitor are independent discriminators of sepsis-induced coagulopathy

ISTH Academy, Faculty / Presenters, 4150085

Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura

ISTH Academy, X.long Zheng, 4150086

Hospital-acquired venous thromboembolism among critically ill children with diabetic ketoacidosis: a multicenter, retrospective cohort study

ISTH Academy, , 4150087

Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial

ISTH Academy, Faculty / Presenters, 4150088

Comparable hemostatic capacity of blood taken from the portal vein compared with systemic blood in patients with cirrhosis

ISTH Academy, Faculty / Presenters, 4150089

Great white sighting: a case of heparin-induced thrombosis with thrombocytosis

ISTH Academy, Faculty / Presenters, 4150090

A cluster of pediatric VITT-like cases with thrombosis and thrombocytopenia following respiratory infections-Case series

ISTH Academy, Helen Pergantou, 4150091

Fibrinaloid microclots in long COVID: assessing the actual evidence properly

ISTH Academy, , 4150092

Distinguishing hyperfibrinolysis from enhanced–fibrinolytic-type disseminated intravascular coagulation

ISTH Academy, Faculty / Presenters, 4150093

Reported particles are not blood clots, so anticoagulant drugs are not a plausible treatment

ISTH Academy, Faculty / Presenters, 4150094

Corrigendum to ‘Hand grip strength and risk of incident venous thromboembolism: The Tromsø study’

ISTH Academy, Faculty / Presenters, 4150095

An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B

ISTH Academy, Raimondo De Cristofaro, 4147415

Characterization of recombinant factor IX fusion proteins enabling subcutaneous administration

ISTH Academy, Faculty / Presenters, 4147414

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs

ISTH Academy, Sophie Susen, 4147413

Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A

ISTH Academy, Andreas Tiede, 4147412

Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice

ISTH Academy, Thomas Girard, 4147411

Keep it positive: loss of positive charge induced by R1205H von Willebrand factor change accelerates von Willebrand factor clearance through enhanced binding to macrophage clearance receptors LRP1 and SR-A1

ISTH Academy, Giancarlo Castaman, 4147410

First impressions

ISTH Academy, Faculty / Presenters, 4147409

Issue Information

ISTH Academy, Faculty / Presenters, 4147408

Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients

ISTH Academy, Francesco Violi, 4147425

Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation

ISTH Academy, Anetta Undas, 4147423

Safety and efficacy of direct oral anticoagulants in chronic kidney disease: a meta-analysis

ISTH Academy, , 4150080